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Eugenia dysenterica is a plant typically found in the Cerrado biome and commonly used in popular medicine due to its
pharmacologicalproperties,whichincludeantidiarrheal,skinhealing,andantimicrobialactivities.Theeﬀectsofethanolicextract,
aqueous extract and infusion of E. dysenterica leaves on intestinal motility and antidiarrheal activity were evaluated using ricin oil-
induced diarrhea in rats. At doses of 400 and 800mg·Kg
−1, the ethanolic extract decreased intestinal motility while the other
extracts showed no signiﬁcant eﬀects. Moreover, serum levels of chloride, magnesium, and phosphorus were also measured in
rats. Histopathologic and enzymatic analyses were also performed to investigate any toxic eﬀect. Animals treated with infusion,
ethanolic extract, ricin oil, and loperamide presented morphological alterations in the small intestine, such as mucosa lesion,
epithelial layer damage, and partial loss and/or morphological change of villi. Furthermore, the liver showed congestion and
hydropic degeneration. Serum levels of alanine aminotransferase increased signiﬁcantly in all treatments, but none rose above
reference values. In summary, our results suggest that compounds present in leaves of E. dysenterica may have therapeutic beneﬁts
on recovery from diarrhea despite their toxic eﬀects.
1.Introduction
Diarrhea is responsible for deaths in adults and especially
children all over the world, particularly in developing
countries [1, 2]. In general, chronic diarrhea can develop
from congenital problems, neoplastic syndrome, human
immunodeﬁciency virus (HIV), adverse eﬀects of medica-
tions, and, most commonly, is caused by gastrointestinal
infections including viral/bacterial gastroenteritis [3, 4]. In
general, patients with uncontrolled diarrhea are at increased
risk of dehydration, electrolyte imbalance, skin breakdown,
and fatigue. In many cases the treatments utilized are oral
rehydration therapy (ORT) and pharmacological interven-
tion, including antibiotics and antidiarrheal drugs, which
cause a pronounced eﬀect on gut motility, thus decreasing
intestinal transit [5, 6]. Currently, the search for antidiar-
rheal therapies should include allopathic, homeopathic, and
alternative medical approaches that have demonstrated their
ability to reduce the duration and severity of diarrhea in
children in developing countries [7].
In view of a number of disease properties including
epidemiology, etiological agents, and changeable clinical
manifestations depending on the region, diﬀerent strategies
have been applied to control diarrhea [8]. In order to reduce
infections caused by bacterial pathogens, the Diarrheal
Disease Control program created in 1978 by the World
Health Organization (WHO) puts special emphasis on the
use of traditional (folk) medicines in the control and2 Evidence-Based Complementary and Alternative Medicine
management of diarrhea [9]. The regional Western Paciﬁc
Oﬃce of the WHO included diarrhea as a target disease
[10]. Currently, screening of biological products and phy-
tochemical extracts has been encouraged to obtain isolated
plant biomolecules with antidiarrheal activity, including
various plant families such as Liliaceae [11], Rubiaceae [12],
Meliaceae [13], Fabaceae [14], Myrtaceae [15], and several
others.
Eugenia dysenterica DC., known as “cagaita”, is a fruit-
bearing tree of the Myrtaceae family native to the Brazilian
Cerrado (upland savannah). This plant is widely used by the
population in the treatment of various diseases; tea from its
leaves is used to treat diarrhea, diabetes, and jaundice; tea
fromitsﬂowersisusedtotreatkidneyandbladderinfections;
its fruit is used as a laxative [16]. Considering that cagaita
leaf tea is the main way in which this plant is used as a
popular alternative medicine in Latin America, the present
study was conducted to evaluate the possible antidiarrheal
eﬀect of the leaves of E. dysenterica, analyzing antimotility
and antisecretory actions. Furthermore, the possible toxic
eﬀects were evaluated in a rat model by histopathological
analysis.
2.MaterialandMethods
2.1. Plant Material and Extract Preparation. Leaves from E.
dysentericawerecollectedintheCerradobiome,fromanarea
of upland savannah surrounding Brasilia-DF, Brazil. Leaves
were dried at 30
◦C in a circulating air oven. One hundred
grams of leaf powder was subjected to sequential extraction
using solvents of increased polarity to aﬀord dry extracts of
hexane 100% in a proportion of 3:1 (w/v), ethanol 100%
in a proportion of 3:1 (w/v), and deionized water (1:1)
to give hexanic, ethanolic, and aqueous extracts [16]. The
solvent of ethanolic extract was evaporated under vacuum
in a rotary-evaporator at 45
◦C and further stored at 24
◦C.
A q u e o u se x t r a c tw a sl y o p h i l i z e da n ds t o r e da t−20
◦C. The
powdered leaves (100g) were also macerated and extracted
with deionized water for 24 hours at 40
◦C under 120rpm
agitation. After cooling, the resulting extract was ﬁltered
through 8µm ﬁlter paper and lyophilized. For bioactivity
investigations, all extracts were soluble in distilled water.
None diﬃculty in the extract solubilization was observed.
Percentage yields of the hexanic, ethanolic, and aqueous
extracts and of the infusion were, respectively, 8.78%, 22.1%,
22.4%, and 20.0% of dry weight.
2.2. Animals. Male adult Wistar rats (Rattus norvegicus)
weighing 280–300g were acquired at the Biotery of the
Universidade Cat´ olica de Bras´ ılia. All animals were used after
1 week of acclimatization (temperature 23 ± 2◦C humidity
60%) and had free access to water and food. The study
was approved by the Animal Use Committee (CEUA) at
the Institute of Biological Sciences, University of Brasilia.
Project number 0177–07 was approved on 27.03.07 under
the name “Activity of drugs in the presence or absence
of nanocapsules and/or magnetic ﬂuids in the treatment
of several diseases in experimental animal models”. The
experiments reported here comply with ethical procedures
with investigated animals [17].
2.3. Assessment of Gastrointestinal Propulsion of Charcoal
Meal. EvaluationofantidiarrhealeﬀectsofE.dysentericawas
conducted according to the method described by Abdullahi
et al. [18]. Forty rats were separated in ﬁve groups of eight
animals. The positive control group received loperamide
orally, at the dose of 2mg·kg−1
, and the negative group
received 1mL of water; test groups received the infusion
or aqueous extract at doses of 800mg·kg−1 or ethanolic
extract at doses of 400mg·kg−1 resuspended in 1mL of
water. This procedure was determined according to Sagar
et al. [19], Mbagwu and Adeyemi [20], Ojewole et al. [21],
Mujumdar et al. [22], and Afroz et al. [23] with minor
modiﬁcations. Test animals were starved for 12 hours prior
to the experiment, but consumed water ad libitum.T e n
min later, animals from each group were fed on 1mL of
charcoal meal (3% suspension of deactivated charcoal in
0.5% aqueous methylcellulose). Thirty minutes after the
administration of charcoal meal, the animals from each
group were killed by using CO2, and intestine length
(pyloric sphincter to caecum) was measured, as well as the
distance along which the charcoal moved as a fraction of
that length, in accordance with the procedure described
by Nwafor et al. [11] .T h em e a nv a l u ef o re a c hg r o u p
was calculated and results obtained in the control and test
groups were compared. Percentage inhibitions of intestinal
motility were calculated by using the equation (nega-
tive control mean—treated (test) mean)/negative control
mean × 100.
2.4. Evaluation of Serum Levels. Analyses of ionic absorption
and acute and subchronic toxicity after ricin oil-induced
diarrhea were conducted according to the method described
by Sagar et al. [19] with some modiﬁcations. Rats were
divided into six groups of eight animals; diarrhea was
induced by administering 1ml of ricin oil orally using an
intragastric tube. Thirty minutes after the administration of
ricin oil, the animals received the treatments. The positive
control group received loperamide orally, at the dose of
2mg·kg−1. The negative control was divided in to two
groups including animals treated orally with 1 mL of ricin
oil or 0.2mL of water using an intragastric tube. Test
groups received the infusion or aqueous extracts at doses
of 800mg·kg−1 or the ethanolic extract at the dose of
400mg·kg−1, resuspended in 0.2mL of water. This assay
was conducted for twenty-two days, after which the blood
to be used for the evaluation of serum levels was collected
from all animals. After diﬀerent drug administration periods
(no administration—T0, one dose—T1, repeated doses for
7 days—T2, and repeated doses for 14 days—T3), 1 mL of
bloodwascollectedbyheartpuncture,withoutanticoagulant
substances, in order to obtain serum samples, and further
analyzed according to several biochemical variables such as
chloride, magnesium, phosphorus, and alanine aminotrans-
ferase by using commercial kits (Labtest Diagnostic S.A.,
Lagoa Santa-MG, Brazil).Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Evaluation of antimotility activity after administration
of infusion and aqueous extract at the dose of 800mg·kg−1 and
e t h a n o l i ce x t r a c ta tt h ed o s eo f4 0 0m g ·kg−1. The positive control
group received loperamide at the dose of 2mg·kg−1, and the
negative control group was given 1mL of water orally. Vertical
barsrepresentstandarderror.Asterisksindicatestatisticaldiﬀerence
from control (P ≤ .05) by Dunnett test.
2.5. Histopathological Analysis. All animals that survived 22
days of treatment were submitted to laparotomy for removal
of the small intestine and liver. These tissues were ﬁxed
in 10% neutral buﬀered formalin. The ﬁxed samples were
dehydrated in an ascending series of ethanol, cleared in
methyl benzoate, and embedded in paraﬃnw a x .F o u r - µm-
thick sections were obtained using a microtome and stained
with hematoxylin and eosin. The photomicrographs were
taken by digital camera (AxioCam MRc 5, Carl Zeiss) driven
by software Axio Vision 4.6.3. (Carl Zeiss) coupled with
an optical microscope (Carl Zeiss). Tissue lesion in the
intestine was classiﬁed by the occurrence of villi alterations
and ulceration or inﬂammatory process. Tissue lesion of the
liver was determined by the presence of congestion, hydropic
andfattydegeneration,inﬂammatoryinﬁltrate,andnecrosis.
2.6. Statistical Analysis. Results were expressed as means ±
SD of four separate experiments. Data from all assays were
subjected to a Shapiro-Wilk test of normality statistical anal-
ysis of data obtained was performed using one-way analysis
of variance (ANOVA), and the diﬀerences among group
means were analyzed using Dunnett’s multiple comparisons
test. Analysis was performed using BioEstat software (v. 5.0).
Values were held to be signiﬁcant if P < .05.
3. Results
3.1. Eﬀect of Leaf Samples of E. dysenterica on Gastrointestinal
Transit of Charcoal Meal. Initially, experiments carried out
on intestinal transit after charcoal meal administrations were
conduced. The ethanolic extract at the dose of 400mg·kg−1
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Figure 2: Analysis of the antisecretory eﬀect of infusion, ethanolic
and aqueous extract of E. dysenterica utilizing as parameters
alterations in serum chloride levels at diﬀerent periods: no treat-
ments (T0), after one dose (T1), seven-day dose (T2) and 14-
day dose (T3). Negative control group received 1mL of water and
ricin oil (10mg·kg−1). Positive control group received loperamide
(2mg·kg−1) and experimental groups received infusion and aque-
ous extract at the dose of 800mg·kg−1 and ethanolic extract at
t h ed o s eo f4 0 0 m g ·kg−1. Vertical bars represent standard error.
Asterisks indicate statistical diﬀerence from control (P ≤ .05) by
Dunnett test.
and loperamide at the dose of 2mg·kg−1signiﬁcantly inhib-
ited (P < .05) intestinal transit in rats by 24% and 37%,
respectively (Figure 1). Nevertheless, aqueous extract and
infusion did not cause any eﬀect on intestinal transit,
showing similar data to those of the negative control (water).
3.2. Evaluation of Ion Absorption after Ricin Oil-Induced
Diarrhea. In the present study, diarrhea was induced with
ricin oil, and the antidiarrheal that eﬀect produced by
samples was analyzed utilizing chloride, magnesium, and
phosphorus levels at diﬀerent periods. In animals treated
with loperamide, levels of chloride increased by 41.2%
(P < .05) (Figure 2). Animals treated with the aqueous and
ethanolic extracts also showed a signiﬁcant increase in levels
of chloride, by 20.0% and 30.0%, respectively (P < .05). The
other treatments showed no signiﬁcant variation in serum
levels of chloride with a consecutive dose of 800mg·kg−1 for
ap e r i o do f1 4d a y s( Figure 2).
Analysis of phosphorus concentration showed initial
decrease in animals’ serum levels when treated with ricin oil
(23%), loperamide (33%), aqueous extract (10%), ethanolic
extract (18%), and infusion (33%) (Figure 3). Phosphorous
in these groups decreased signiﬁcantly (P < .05) after the
administration of only one dose. Continued use could
lead to hyperphosphatemia in animals treated with ricin
oil (80.5%), loperamide (68.4%), aqueous extract (85.4%),4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Analysis of antisecretory eﬀect of infusion, ethanolic
and aqueous extracts of E. dysenterica utilizing as parameters
alterations in serum phosphorus levels at diﬀerent periods: no
treatments (T0), after one dose (T1), seven-day dose (T2), and 14-
day dose (T3). Negative control group received 1mL of water and
ricin oil (10mg·kg−1). Positive control group received loperamide
(2mg·kg−1), and experimental groups received infusion and aque-
ous extract at the dose of 800mg·kg−1 and ethanolic extract at
t h ed o s eo f4 0 0 m g ·kg−1. Vertical bars represent standard error.
Asterisks indicate statistical diﬀerence from control (P ≤ .05) by
Dunnett test.
ethanolic extract (75.7%), and infusion (75.7%) (P < .05)
(Figure 3).
Magnesium level analyses of serum were altered in rats
treated with ricin oil (165%), loperamide (82.8%), aqueous
extract (58.8%), ethanolic extract (53%), and infusion
(82.8%) (P < .05) (Figure 4). These alterations in serum
magnesium levels were mainly observed after consecutive
doses (T3), causing a clear increase of over 100%. Moreover,
it is important to observe that in all analyses of serum levels,
theanimalsthatreceived1mLofwater(negativecontrol)did
not show any modiﬁcations in the concentrations of this ion.
3.3. Histopathological Analysis. The histopathological anal-
ysis of the animals, after 22 days of administration of
treatments, showed signiﬁcant alterations in intestine and
liver tissue. In general, the small intestine evidenced the
presenceofaninﬂammatoryprocesscausedtoalltestgroups.
However,intheanimalstreatedwithinfusion,itisimportant
to note the presence of intense inﬂammatory inﬁltrate,
partial loss of intestinal villi, and a complete mucosal
alteration (Figure 5(b)). Animals that received ethanolic
extractshowedcongestionandchangesinthemorphologyof
the villi (Figure 5(c)). Ulceration and intense inﬂammatory
inﬁltrate were observed in animals treated with aqueous
extract and ricin oil (Figures 5(d) and 5(e), resp.). Animals
that received loperamide showed changes and destruction in
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Figure 4: Analysis of antisecretory eﬀect of infusion, ethanolic and
a q u e o u se x t r a c t so fE. dysenterica utilizing alterations in serum
magnesium levels at diﬀerent periods: no treatments (T0), after
one dose (T1), seven-day dose (T2) as parameters, and 14-day
dose (T3). Negative control group received 1mL of water and
ricin oil (10mg·kg−1). Positive control group received loperamide
(2mg·kg−1), and experimental groups received infusion and aque-
ous extract at the dose of 800mg·kg−1 and ethanolic extract at
t h ed o s eo f4 0 0 m g ·kg−1. Vertical bars represent standard error.
Asterisks indicate statistical diﬀerence from control (P ≤ .05) by
Dunnett test.
themorphologyofthevilli(Figure 5(c)).Moreover,itshould
be noted that aqueous extract and ricin oil caused greater
damage to the intestinal tissue than to the other analyzed
groups.
Histopathological analysis of the liver after infusion
revealed that the sample caused congestion in the centrolob-
ular veins, and this symptom could be associated with a con-
gestion focus in the sinusoid capillary, hydropic degenera-
tion, and portal/periportal oedema formation (Figure 6(b)).
Similar data were observed in animals that received ricin oil,
and a cluster of cords of hepatocytes was also described in
association with this alteration, except for the presence of an
inﬂammatory process and the absence of portal/periportal
oedema formation in this group (Figure 6(e)). It should be
emphasized that animals that received water did not show
any modiﬁcation (Figures 5(a) and 6(a)). Furthermore, the
consecutiveadministrationofloperamidecausedthegreatest
liver alterations. Animals that received loperamide, ethanolic
and aqueous extracts showed hydropic degeneration, sinu-
soidal congestion in the capillaries, and portal/periportal
oedema formation (Figure 6(f)).
3.4. Analysis of Serum Alanine Aminotransferase. The levels
of alanine aminotransferase (ALT) increased in animals
treated with ricin oil (54%), loperamide (54%), and aqueous
extract (26%) (Figure 7). It is noteworthy that despiteEvidence-Based Complementary and Alternative Medicine 5
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Figure 5: Small intestine sections of rats treated with water (a), infusion of leaves of E. dysenterica (b), ethanolic extract of leaves of E.
dysenterica (c), aqueous extract of leaves of E. dysenterica (d), ricin oil (e) and loperamide (f). The arrows indicate intense mononuclear cell
inﬂammatory inﬁltrate in the mucosa and submucosa; arrow tips indicate changes in villi morphology and the asterisk indicates congestion.
the increase in enzyme serum levels and tissue damage
observed in the histopathological analysis, none of the
treatmentsexceededthereferencerangeforthisrat’senzyme,
which is 35.1 ± 13.3 U/L [19].
4. Discussion
Diarrhea is a consequence of innumerable pathologic con-
ditions. Usually diarrhea is caused by altered motility and
ﬂuid accumulation in the intestine lumen, which can be
occasioned by an increased secretion of electrolytes (secre-
tory diarrhea), an enhanced ingestion of osmotic substances
(osmotic diarrhea), or the presence of a virulent microor-
ganism (infectious diarrhea) [3, 6, 24]. For this reason,
in the present study, antidiarrheal properties of infusion,
ethanolicandaqueousextractsofleavesofE.dysentericawere
examined using various parameters, including intestinal
motility and ionic absorption.
It was shown that the ethanolic extract of leaves of
E. dysenterica signiﬁcantly inhibited intestinal transit in
rats, while the other two extracts were unable to do that.
Similar eﬀects are described by Sagar and collaborators [19]
with the use of Lantana camara methanolic extract against
neostigmine as promotility agent. Khan and collaborators
in [25] showed the antidiarrheal activity from Arque-
Ajeeb, a mixture of Mentha arvensis, Trachyspermum ammi,
and Kaphoor, which was able to inhibit intestinal transit
in serotonin-induced diarrhea and PGE2-induced small
intestine enteropooling. Various plant extracts are described
as having antidiarrheal activity, such as aqueous extracts of
Guierasenegalensis roots [26]andByrsocarpuscoccineus[27],
andalsomethanolextractsofXylocarpusgranatumbark[12],
Asparagus pubescens root [10], Dalbergia lanceolaria bark
[13], and others.
Antidiarrhealactivitywasfoundinplantspossessingtan-
nins,alkaloids,saponins,ﬂavonoids,steroids,andterpenoids6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Liver sections of rats treated with water (a), infusion of leaves of E. dysenterica (b), ethanolic extract of leaves of E. dysenterica (c),
aqueous extract of leaves of E. dysenterica (d), ricin oil (e) and loperamide (f), The arrows indicate congestion in the centrolobular vein,
the arrow tips show congestion in the capillary sinusoids and the asterisks indicate hydropic degeneration in b and fatty degeneration in d.
Figures b and f also show portal/periportal oedema formation. Figure e present numerous inﬂammatory process spots.
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Figure 7: Evaluation of hepatotoxicity in rats after oral administration of infusion, ethanolic and aqueous extract of E. dysenterica utilizing
as parameters alterations in the levels of serum (U/L) alanine aminotransferase (ALT) enzyme. Values of mean and standard deviation of
the eﬀect exerted by the samples at diﬀerent periods: no treatments (T0), after one dose (T1), seven-day dose (T2) and 14-day dose (T3).
Negative control group received 1mL of water and ricin oil (10mg·kg−1). Positive control group received loperamide (2mg·kg−1)a n d
experimental groups received infusion and aqueous extract at the dose of 800mg·kg−1 and ethanolic extract at the dose of 400mg·kg−1.
Vertical bars represent standard error. Asterisks indicate statistical diﬀerence from control (P ≤ .05) by Dunnett test.Evidence-Based Complementary and Alternative Medicine 7
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Figure 8:HypotheticaldiagramsummarizingtheeﬀectofethanolicandaqueousextractsandinfusionofE.dysentericaonthesmallintestine
and liver.
[28]. Abascal and Yarnell in [29] comment on the tendency
to use plants for treatment of irritable bowel syndrome
(IBS). These authors describe the use of bayberry (Morella
cerifera)r o o tb a r k ,m e a d o w s w e e t( Filipendula ulmaria)l e a f
and cranesbill (Geranium maculatum) root; these plants all
produce tannins that bind the ﬂuid in the colon, inhibiting
the protective excretory function of diarrhea. Antidiarrheal
activity is also described in the model of secretory diarrhea
induced by cholera toxin, after ingestion of a mixture of SP-
303 with procyanidin oligomers derived from the latex of
Croton lechleri, known as Sangre de Drago [30].
The antidiarrheal activity of these compounds has
been attributed to antimotility and antisecretory eﬀects,
and/or antimicrobial action [31]. In general, the presence
of secretory diarrhea results in various electrolyte disorders.
In the present study it was observed that the ethanolic
extract of E. dysenterica causes electrolytic disturbance
(aﬀecting levels of chloride, magnesium, and phosphorus).
Ion concentration analyses suggest that the antidiarrheal
action was not caused by an antisecretory mechanism in the
diarrhea model induced by ricin oil. It is known that ricin
oil causes secretory diarrhea, since ricinoleic acid induces
diarrhea through a hypersecretory response [32, 33]. Ricin
oilreducesNa+ andK+ absorptionanddecreasesNa+ andK+
ATPase activity. These actions, related to ricin oil’s diarrheal
eﬀects, are involved in adenylate cyclase activation, secretion
of mucosal cAMP, induction of platelet activating factor,
increase in prostaglandin biosynthesis, and modiﬁcation of
nitric oxide concentration [12–34]. Although these numer-
ous mechanisms have been proposed, the overall consensus
is that ricin oil-induced diarrhea stimulates prostaglandin
formation; consequently, a drug that decreases the synthesis
of prostaglandins can be used in the treatment of diarrhea
[14–34].
Kaysar and collaborators [35] reported that the lowest
serum phosphate concentration is associated with laxative
abuse, which occasions severe diarrhea, resembling that
induced by ricin oil. This showed that after one dose, these
samples probably have no antidiarrheal activity. Moreover,
phosphorusconcentrationbeingaﬀectedbydiﬀerentfactors,
such as vitamin D overdoses and laxative abuse or enemas
(which are also absorbed when given rectally), occasions
severe diarrhea [36]. In general, when serum phosphorus
levels decrease, reduction in urinary phosphorus excretion
and stimulation of the 1-alpha hydroxylase enzyme in the
kidneys were observed [37]. However, in the presence of
hyperphosphatemia, as observed after prolonged use of all
samples, including loperamide (positive control), a rapid
increaseinurinaryexcretionofphosphorusoccurs,mediated
bytheserumphosphoruslevel,parathyroidhormone(PTH),
and ﬁbroblast growth factor 23 (FGF23) [38]. This probably
explains why loperamide has no direct eﬀect on absorption,
since its action mechanism is related to interaction with
the µ-opioid receptor, prolonging intestinal transit [39].8 Evidence-Based Complementary and Alternative Medicine
Abnormalities of chloride, phosphorus, and magnesium
homeostasis are common and can be associated with dehy-
dration caused by diarrhea [40]. Other authors report that
hypomagnesemia involves intestinal loss, malabsorption,
and abnormality of vitamin D and parathyroid hormone
metabolism [41, 42].
Several antidiarrheal present toxicity eﬀects, and for
this reason, we make available the action of the ethanolic
and aqueous extracts and infusion of E. dysenterica on the
small intestine and liver, which is explained in Figure 8.
The histopathological analysis of the small intestine showed
serious injury to intestinal villi in animals treated with
the infusion, ricin oil, and loperamide. The lesions in the
epithelium observed in animals treated with these samples,
including hemorrhage (data not shown), are indicative of
several possible mucosal injuries. Some authors suggest
that intestinal hemorrhage is associated with a signiﬁcant
localized inﬂammatory response in the mucosa and serosa,
whichtheyattributedtointestinalendotoxemia[43,44].The
persistent evidence of inﬂammation in the colonic mucosa
of animals treated with infusion, ricin oil, and loperamide
showed that excessive diarrhea observed could be caused by
changesinepithelialpermeability.Thesemodiﬁcationscould
be related to modiﬁcations in tight junction function, which
are often observed in ulcerative colitis [45].
Histopathological analysis of the liver in animals treated
with loperamide, ethanolic and aqueous extracts showed
hydropic degeneration, sinusoidal congestion in the capillar-
ies and portal/periportal oedema formation. Similar results
were described by Vasconcellos and collaborators [46], using
leaves of Capraria biﬂora. It should be noted that the liver
is a major site for the biotransformation, accumulation and
excretion of exogenous chemicals, and that damage in the
nearby tissue indicates possible toxicity [47].
The most common cause of abnormal liver enzymes
in the sick patient is secondary liver changes that arise
from a primary nonhepatic disease [48]. It is important
to understand the reactive nature of the liver in response
to other disease conditions. In such reactive situations, the
hepatopathy is not the primary hepatic disease [49], and as
we have seen in this study, there is a positive correlation
between liver damage and changes in serum ALT.
An interesting observation, which also causes concern, is
that although the infusion showed no biological activity in
the tests used here, it did, however, present severe damage to
the intestinal tissue and liver. These ﬁndings are worrying,
since the Cerrado population frequently uses tea made from
E. dysenterica leaves in the treatment of diarrhea.
In summary, data reported here demonstrated antidiar-
rhealactivitybyinhibitinggastrointestinalmotilityinanimal
models. Due to these ﬁndings, we believe that E. dysenterica
could be a potential source of a new antidiarrheal drug,
despite the above-mentioned toxicological eﬀects. Results
presented here conﬁrm the popular use of E. dysenterica
and its well known medical properties in folklore medicines.
These data are extremely important, since the use of medic-
inal plants has recently increased in developed countries
because of disillusionment with traditional medicine. In
developing countries, the strategy of alternative medicine
continues to be used due to low costs and abundant
availability. The contribution of traditional knowledge can
improve the development of more eﬀective drugs with
minimalornosideeﬀects,alsohelpingtoconservebiological
resources.
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